Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05959200 · ClinicalTrials.gov registry record · NA
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT05959200: Completed NA study, sponsored by Alcon Research.
NCT05959200 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05959200, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.
Primary Outcome
The investigator will view the contact lens through a slit lamp (biomicroscope) and record the axis orientation (-179° to +180°) as the number of degrees away from the ideal location (90° axis) either positive or negative depending on the direction (nasal \[+\] or temporal \[-\]). No hypothesis testing was prespecified for this endpoint.
Interventions
- DEVICE CLEAR CARE
- DEVICE Serafilcon A toric contact lenses
- DEVICE Senofilcon A toric contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2023-08-14 |
| Est. Completion | 2023-10-23 |
| Phase | NA |
What the finished NCT05959200 record still lists
NCT05959200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which CLEAR CARE is the first listed.
NCT05959200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05959200 about?
NCT05959200 is a clinical study titled "Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses". The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.
What is the current status of trial NCT05959200?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2023-08-14. Estimated completion is 2023-10-23.
What interventions are being tested in trial NCT05959200?
The interventions under investigation include: CLEAR CARE (DEVICE), Serafilcon A toric contact lenses (DEVICE), Senofilcon A toric contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05959200?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05959200's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI